Trial
NCT03020472
Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
Influenza
Intervention
2008-2009 FluMist LAIV (Intranasal)
Why stopped
Due to low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-18